Trifluoromethylbenzamide derivatives and therapeutic uses...

Details Trifluoromethylbenzamide derivatives and therapeutic uses... Trifluoromethylbenzamide derivatives and therapeutic uses...

2011-05-24

2011-05-24

Jarrell, Noble (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S211010, C514S212010, C514S226800, C514S227500, C514S228800, C514S231200, C514S277000, C514S315000, C514S359000, C514S365000, C514S372000, C514S374000, C514S385000, C514S613000, C540S484000, C540S544000, C540S553000, C544S003000, C544S053000, C544S056000, C544S063000, C544S088000, C544S098000, C546S001000, C548S125000, C548S146000, C548S206000, C548S215000, C548S240000, C564S123000

Reexamination Certificate

active

07947675

ABSTRACT:
Compounds of the formula (I), in which the radicals R1to R3and AR are as defined in the description, processes for the preparation thereof, the use thereof in the treatment of cardiovascular diseases, and pharmaceutical compositions comprising them.

REFERENCES:
patent: 6207671 (2001-03-01), Schmidt et al.
patent: 7138414 (2006-11-01), Schoenafinger et al.
patent: 0 818 448 (1998-01-01), None
patent: WO 2004/007455 (2004-01-01), None
patent: WO 2004/017969 (2004-03-01), None
MacLean et al. Journal of Clinical Endocrinology and Metabolism, 2005, 90(4), 2250-58.
Forester et al. Circulation, 2005, 111, 1847-54.
Dixit et al. BMC Endocrine Disorders, 2005, 5:7, 1-10.
“Diabetic Neuropathy”, http://www.healthscout.com/ency/68/90/main.html, accessed May 19, 2010.
Williamson et al., Annals of Internal Medicine, 2004, 140(11), pp. 951-957.
“Atherosclerosis”, http://www.healthguidance.org/entry/4736/1/Atherosclerosis—Symptoms-Causes-Prevention-and-Treatment.html, accessed May 19, 2010.
“Obesity: Prevention”, http://www.mayoclinic.com/health/obesity/ds00314/dsection=prevention, accessed May 19, 2010.
Viswanathan, Indian Journal of Nephrology, 2004, 14, 157-162.
Sheibly, Journal of Organic Chemistry, 1952, 17, pp. 221-225.
Ramratap S. Kushwaha et al., “Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons,” Journal of Lipid Research, vol. 34, 1993, pp. 1285-1297, XP002347987.

Affiliated with

Also associated with

Rating

Trifluoromethylbenzamide derivatives and therapeutic uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Trifluoromethylbenzamide derivatives and therapeutic uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trifluoromethylbenzamide derivatives and therapeutic uses... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2689381